Search hospitals
>
Florida
>
Miami
University of Miami
Claim this profile
Miami, Florida 33136
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Diabetes
Conducts research for HIV Infection
Conducts research for Lung Cancer
1134 reported clinical trials
182 medical researchers
Summary
University of Miami is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Breast Cancer, Diabetes, HIV Infection, Lung Cancer and other specialties. University of Miami is involved with conducting 1,134 clinical trials across 1,253 conditions. There are 182 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Danielle Horn, and David Baidal, Dr..
Area of expertise
Cancer
University of Miami has run 53 trials for Cancer. Some of their research focus areas include:
Breast Cancer
University of Miami has run 46 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Julio C Barredo, MD
University of Miami Miller School of Medicine-Sylvester Cancer Center
8 years of reported clinical research
Jose Lutzky, MD
University of Miami
5 years of reported clinical research
Danielle Horn
University of Miami Don Suffer Clinical Research Building
5 years of reported clinical research
David Baidal, Dr.
Diabetes Research Institute, University of Miami Miller School of Medicine
2 years of reported clinical research
Clinical Trials running at University of Miami
Breast Cancer
Non-Hodgkin's Lymphoma
Parkinson's Disease
Lymphoma
B-Cell Lymphoma
Multiple Myeloma
Cancer
Depression
Colorectal Cancer
Acute Myeloid Leukemia
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting
2 awards
Phase 3
3 criteria
Farletuzumab Ecteribulin
for Solid Cancers
The primary objectives of the study are: (1) in the dose-escalation part: to evaluate safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of farletuzumab ecteribulin (MORAb-202) in participants with selected tumor types (ovarian cancer \[OC\], endometrial cancer \[EC\], non-small cell lung carcinoma \[NSCLC\], triple-negative breast cancer \[TNBC\]), and (2) in dose-confirmation part: to evaluate preliminary efficacy measured by objective response rate (ORR) of farletuzumab ecteribulin (MORAb-202) in participants with OC and EC at selected doses and to further evaluate the safety and tolerability of farletuzumab ecteribulin (MORAb-202) and (3) dose-optimization part. (divided in two parts: Part A \[OC and EC participants\] and Part B \[OC only\]): Part A: to evaluate other farletuzumab ecteribulin (MORAb-202) treatment regimens for safety, tolerability and preliminary efficacy in participants with OC and EC; to evaluate the addition of short course of oral corticosteroids following every dose of farletuzumab ecteribulin (MORAb-202) administered every 21 days; and to select treatment regimens with farletuzumab ecteribulin (MORAb-202) for further evaluation in Part B. Part B: to evaluate the safety and tolerability of different doses of farletuzumab ecteribulin (MORAb-202) as monotherapy and in combination with lenvatinib and to determine the recommended dose (RD) of farletuzumab ecteribulin (MORAb-202) as monotherapy and in combination with lenvatinib.
Recruiting
1 award
Phase 1 & 2
IAM1363
for Breast Cancer
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.
Recruiting
1 award
Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Miami?
University of Miami is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Breast Cancer, Diabetes, HIV Infection, Lung Cancer and other specialties. University of Miami is involved with conducting 1,134 clinical trials across 1,253 conditions. There are 182 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Danielle Horn, and David Baidal, Dr..
Where is University of Miami located?
To reach the University of Miami Hospital, from I-95 take S.R. 836 West, exit at N.W. 12th Avenue and proceed north to the medical center complex at N.W. 16th Street. Alternatively, from S.R. 836 East, exit at N.W. 17th Avenue North, turn right onto N.W. 17th Avenue, right at N.W. North River Drive, left at N.W. 13th Terrace, right onto N.W. 14th Street, and continue to N.W. 12th Avenue.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Miami Hospital, visit the Office of Student Financial Assistance and Employment located at 1306 Stanford Drive, Suite 1210, Coral Gables, FL 33146, or call 305-284-3004. UHealth has appointed Aetna as its primary behavioral health administrator for insurance-related inquiries. International patients can benefit from bundled package pricing for self-pay options and insurance coverage verification for insured patients.
What insurance does University of Miami accept?
The University of Miami Hospital accepts a wide range of insurance plans, including but not limited to Aetna Medicare (HMO/PPO), Aetna Medicaid (HMO), AvMed Medicare (HMO), and BCBS of FL (excluding SELECT Plans). It also contracts with several managed health organizations, such as Freedom Health Medicare (HMO), Humana Medicare (HMO), and Solis Health Plans. Furthermore, all indemnity insurance products, Champus, Workers Compensation, Medicare, and Medicaid are accepted at the University of Miami Health System hospitals and clinics.
What awards or recognition has University of Miami received?
The University of Miami Hospital, located in Miami, Florida, is renowned for its exceptional staffing practices, earning the title of the top health care brand in the nation for employment. Furthermore, the University of Miami Miller School of Medicine has been awarded over $175 million in funding from the National Institutes of Health, marking the highest amount in its history, dedicated to research and care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.